US Patent Issued to Horizon Therapeutics Ireland DAC on June 9 for "Immunocytokines for treatment of autoimmune and inflammatory conditions" (Maryland, Massachusetts Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,782, issued on June 9, was assigned to Horizon Therapeutics Ireland DAC (Dublin).

"Immunocytokines for treatment of autoimmune and inflammatory conditions" was invented by Partha S. Chowdhury (Gaithersburg, Md.), Yong Jun Liu (Gaithersburg, Md.), Shino Hanabuchi (Clarksburg, Md.) and Nazzareno Dimasi (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to fusion proteins comprising a Tumor Necrosis Factor Alpha (TNFAlpha) binding protein and an interleukin-10 (IL-10) molecule, methods of making the fusion proteins, and methods of treating or preventing autoimmune and inflammatory conditions using the fusio...